Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
JPMorgan Chase & Co. increased their price target on Oric Pharmaceuticals from $17.00 to $20.00 and gave the company an "overweight" rating in a report on Tuesday...